Srinidhi Varadharajan

14PUBLICATIONS
104CO-AUTHORS
Haematological tumoursReaction engineering (excl. nuclear reactions)Molecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 26, 2026
Dominant clones leverage developmental epigenomic states to drive ependymoma.

Alisha S Kardian, Hua Sun, Siri Ippagunta

|Aug 27, 2025
Synthetic ZFTA fusions pinpoint disordered protein domain acquisition as a mechanism of brain tumorigenesis.

A Arabzade, H K Shirnekhi, S Varadharajan

|Jun 30, 2025
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response.

Sanya Mehta, Siri Ippagunta, Srinidhi Varadharajan

|Jul 31, 2024
Histone serotonylation regulates ependymoma tumorigenesis.

Hsiao-Chi Chen, Peihao He, Malcolm McDonald

|Dec 05, 2022
K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas.

Selin Jessa, Abdulshakour Mohammadnia, Ashot S Harutyunyan

|Jul 20, 2022
Sox9 directs divergent epigenomic states in brain tumor subtypes.

Debosmita Sardar, Hsiao-Chi Chen, Amanda Reyes

Pageof 3

Frequent Collaborators

9 joint publications

Stephen C Mack

4 joint publications

Claudia L Kleinman

3 joint publications

Tuyu Zheng

3 joint publications

Michael D Taylor